Paul Song Email

CEO and Chairman . NKGen Biotech

Current Roles

Employees:
71
Revenue:
$11M
About
NKGen Biotech is a clinical-stage biotechnology company harnessing the power of the body's immune system through the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform.\n\nThe mission of NKGen Biotech is to improve patients' lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics. \n\nMore information can be found on our website www.nkgenbiotech.com
NKGen Biotech Address

Santa Ana, CA
United States
NKGen Biotech Email